NCT02279433 2025-06-24A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of DS-6051bNuvation Bio Inc.Phase 1 Completed46 enrolled
NCT02489903 2025-03-17RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)EpicentRx, Inc.Phase 2 Completed139 enrolled 14 charts
NCT02948946 2021-08-04Clinical Utility Assay as a Biomarker for Gastroenteropancreatic and Lung Neuroendocrine TumorsH. Lee Moffitt Cancer Center and Research InstituteCompleted105 enrolled